|
|
|
|
LEADER |
01000caa a22002652 4500 |
001 |
NLM322910609 |
003 |
DE-627 |
005 |
20241013231815.0 |
007 |
cr uuu---uuuuu |
008 |
231225s2021 xx |||||o 00| ||eng c |
024 |
7 |
|
|a 10.1002/adma.202008451
|2 doi
|
028 |
5 |
2 |
|a pubmed24n1566.xml
|
035 |
|
|
|a (DE-627)NLM322910609
|
035 |
|
|
|a (NLM)33734514
|
040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
041 |
|
|
|a eng
|
100 |
1 |
|
|a Maihöfer, Johanna
|e verfasserin
|4 aut
|
245 |
1 |
0 |
|a Hydrogel-Guided, rAAV-Mediated IGF-I Overexpression Enables Long-Term Cartilage Repair and Protection against Perifocal Osteoarthritis in a Large-Animal Full-Thickness Chondral Defect Model at One Year In Vivo
|
264 |
|
1 |
|c 2021
|
336 |
|
|
|a Text
|b txt
|2 rdacontent
|
337 |
|
|
|a ƒaComputermedien
|b c
|2 rdamedia
|
338 |
|
|
|a ƒa Online-Ressource
|b cr
|2 rdacarrier
|
500 |
|
|
|a Date Completed 24.07.2024
|
500 |
|
|
|a Date Revised 13.10.2024
|
500 |
|
|
|a published: Print-Electronic
|
500 |
|
|
|a Citation Status MEDLINE
|
520 |
|
|
|a © 2021 The Authors. Advanced Materials published by Wiley-VCH GmbH.
|
520 |
|
|
|a The regeneration of focal articular cartilage defects is complicated by the reduced quality of the repair tissue and the potential development of perifocal osteoarthritis (OA). Biomaterial-guided gene therapy may enhance cartilage repair by controlling the release of therapeutic sequences in a spatiotemporal manner. Here, the benefits of delivering a recombinant adeno-associated virus (rAAV) vector coding for the human insulin-like growth factor I (IGF-I) via an alginate hydrogel (IGF-I/AlgPH155) to enhance repair of full-thickness chondral defects following microfracture surgery after one year in minipigs versus control (lacZ/AlgPH155) treatment are reported. Sustained IGF-I overexpression is significantly achieved in the repair tissue of defects treated with IGF-I/AlgPH155 versus those receiving lacZ/AlgPH155 for one year and in the cartilage surrounding the defects. Administration of IGF-I/AlgPH155 significantly improves parameters of cartilage repair at one year relative to lacZ/AlgPH155 (semiquantitative total histological score, cell densities, matrix deposition) without deleterious or immune reactions. Remarkably, delivery of IGF-I/AlgPH155 also significantly reduces perifocal OA and inflammation after one year versus lacZ/AlgPH155 treatment. Biomaterial-guided rAAV gene transfer represents a valuable clinical approach to promote cartilage repair and to protect against OA
|
650 |
|
4 |
|a Journal Article
|
650 |
|
4 |
|a IGF-I
|
650 |
|
4 |
|a alginate hydrogel
|
650 |
|
4 |
|a cartilage repair
|
650 |
|
4 |
|a perifocal osteoarthritis
|
650 |
|
4 |
|a rAAV
|
650 |
|
7 |
|a Insulin-Like Growth Factor I
|2 NLM
|
650 |
|
7 |
|a 67763-96-6
|2 NLM
|
650 |
|
7 |
|a Hydrogels
|2 NLM
|
650 |
|
7 |
|a Alginates
|2 NLM
|
700 |
1 |
|
|a Madry, Henning
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Rey-Rico, Ana
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Venkatesan, Jagadeesh K
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Goebel, Lars
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Schmitt, Gertrud
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Speicher-Mentges, Susanne
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cai, Xiaoyu
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Meng, Weikun
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Zurakowski, David
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Menger, Michael D
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Laschke, Matthias W
|e verfasserin
|4 aut
|
700 |
1 |
|
|a Cucchiarini, Magali
|e verfasserin
|4 aut
|
773 |
0 |
8 |
|i Enthalten in
|t Advanced materials (Deerfield Beach, Fla.)
|d 1998
|g 33(2021), 16 vom: 04. Apr., Seite e2008451
|w (DE-627)NLM098206397
|x 1521-4095
|7 nnns
|
773 |
1 |
8 |
|g volume:33
|g year:2021
|g number:16
|g day:04
|g month:04
|g pages:e2008451
|
856 |
4 |
0 |
|u http://dx.doi.org/10.1002/adma.202008451
|3 Volltext
|
912 |
|
|
|a GBV_USEFLAG_A
|
912 |
|
|
|a SYSFLAG_A
|
912 |
|
|
|a GBV_NLM
|
912 |
|
|
|a GBV_ILN_350
|
951 |
|
|
|a AR
|
952 |
|
|
|d 33
|j 2021
|e 16
|b 04
|c 04
|h e2008451
|